Founded Date: 2009
Total Funding: $106M
Funding Status: M&A
Technology: Neurological Disorders
Last Funding Type: Venture - Series Unknown
Investors Number: 12
Industry: Gene Therapy
Headquarters: Ann Arbor, Michigan, United States
Estimated Revenue: Less than $1M